Philippe Lucas
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Study on ibogaine for methadone dependence treatment aims to establish safe detox protocol through first Phase-II trial. Weekly low-dose evaluations conducted to gather safety and efficacy data for future research.
Jose Carlos Bouso
Artificial Intelligence and psychedelics share complexities as powerful tools impacting humanity's reality and choices. Understanding their potential and regulating them ethically are urgent imperatives for positive impact.
Alexander Beiner, De Kai
Ketamine and psilocybin show promise for health conditions but come with risks, including addiction. This talk challenges the view of drugs as neutral tools and explores their complex nature and
Elias Dakwar
Melissa Etheridge shares her journey of addiction struggles, healing, and founding the Etheridge Foundation to research plant medicine treatments for opioid use disorder. Her mission is to provide more effective
Melissa Etheridge
Harm reduction superheroes delve into risk mitigation and benefit maximization, exploring mindset, setting, and substances for safer drug experiences and systemic change.
Mitchell Gomez, Phoenix aka Mohawk Greene
Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case
Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper
Psilocybin research journey: investigating its use for treating tobacco addiction. Includes pilot study, comparative efficacy study, and upcoming multi-site clinical trial funded by NIDA.
Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.
Sandy Samberg
William Leonard Pickard, once a prominent figure in the drug world, served 20 years in prison for LSD production and now works as a senior advisor for various organizations. His
William Leonard Pickard, Vince Kadlubek
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.